Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Current Topics in Medicinal Chemistry

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Design of Novel Phosphopantetheine Adenylyltransferase Inhibitors: A Potential New Approach to Tackle Mycobacterium tuberculosis.  21:1186-1197. 2021
  • C. elegans as model for drug discovery.  17:2067-2076. 2017
  • Computational screening and design for compounds that disrupt protein-protein interactions.  17:2703-2714. 2017
  • Structure Based Design of CYP51 Inhibitors.  17:30-39. 2017
  • 8-Hydroxyquinoline and hydroxamic acid inhibitors of botulinum neurotoxin BoNT/A.  14:2094-2102. 2014
  • An overview of naturally occurring histone deacetylase inhibitors.  14:2759-2782. 2014
  • Epothilones: From discovery to clinical trials.  14:2312-2321. 2014
  • High-throughput screening technologies for botulinum neurotoxins.  14:2062-2080. 2014
  • Inhibition of botulinum neurotoxin BoNT/A.  14:2043-2043. 2014
  • High specificity in response of the sodium-dependent multivitamin transporter to derivatives of pantothenic acid.  13:837-842. 2013
  • Medicinal chemistry design principles for liver targeting through OATP transporters.  13:857-866. 2013
  • Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules.  11:2997-3021. 2011
  • Artificial hematopoietic stem cell niche: bioscaffolds to microfluidics to mathematical simulations.  11:1599-1605. 2011
  • Discovery of dual orexin receptor antagonists (DORAs) for the treatment of insomnia.  11:696-725. 2011
  • Protein-protein interactions and cancer: targeting the central dogma.  11:258-280. 2011
  • Recent progress in the discovery of non-sarcosine based GlyT1 inhibitors.  10:170-186. 2010
  • Hsp90 inhibition with resorcyclic acid lactones (RALs).  9:1419-1435. 2009
  • RNA interference-based gene expression strategies aimed at sustained therapeutic inhibition of HIV.  9:1065-1078. 2009
  • RNAi and related technologies: applications in medicinal chemistry and drug discovery.  9:1063-1064. 2009
  • Rho kinase (ROCK) inhibitors and their application to inflammatory disorders.  9:704-723. 2009
  • Orexin receptor antagonists: medicinal chemistry and therapeutic potential.  8:977-987. 2008
  • Biosynthesis of enediyne antitumor antibiotics.  8:448-459. 2008
  • Recent advances of MEK inhibitors and their clinical progress.  7:1364-1378. 2007
  • Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors.  6:1883-1896. 2006
  • Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia.  6:771-785. 2006
  • Small molecules and future regenerative medicine.  5:383-396. 2005
  • exo-Glycal chemistry: general aspects and synthetic applications for biochemical use.  5:1431-1457. 2005
  • Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors.  4:1045-1057. 2004
  • Micro- and nanotechnologies for studying cellular function.  3:687-703. 2003
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1568-0266

Electronic International Standard Serial Number (EISSN)

  • 1873-4294

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support